Vasamed Valuation
| VSMD Stock | USD 0.0001 0.00 0.00% |
Vasamed seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Vasamed from inspecting the company fundamentals such as Return On Asset of -0.74, current valuation of 2.89 M, and Price To Earning of (0.33) X as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Vasamed's price fluctuation is very steady at this time. Calculation of the real value of Vasamed is based on 3 months time horizon. Increasing Vasamed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Vasamed pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Vasamed. Since Vasamed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vasamed Pink Sheet. However, Vasamed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The real value of Vasamed Pink Sheet, also known as its intrinsic value, is the underlying worth of Vasamed Company, which is reflected in its stock price. It is based on Vasamed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vasamed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Vasamed helps investors to forecast how Vasamed pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vasamed more accurately as focusing exclusively on Vasamed's fundamentals will not take into account other important factors: About Vasamed Valuation
The pink sheet valuation mechanism determines Vasamed's current worth on a weekly basis. Our valuation model uses a comparative analysis of Vasamed. We calculate exposure to Vasamed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vasamed's related companies.Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Vasamed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Vasamed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vasamed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Vasamed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Vasamed's revenue streams: Identify Vasamed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Vasamed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Vasamed's growth potential: Evaluate Vasamed's management, business model, and growth potential.
- Determine Vasamed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vasamed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Vasamed Pink Sheet analysis
When running Vasamed's price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |